Zobrazeno 1 - 10 of 106 pro vyhledávání: '"Marc, Frenay"'
1
Bevacizumab: Is the lower the better for glioblastoma patients in progression?
Autor: Pierre Thomas, Lydiane Mondot, Laurent Suissa, Véronique Bourg, Denys Fontaine, Marc Frenay, Christine Lebrun-Frenay, Philippe Paquis, Fanny Burel-Vandenbos, Fabien Almairac, Lila Sirven-Villaros
Publikováno v: Bulletin du Cancer. 105:1135-1146
Summary Introduction Based on the radiological responses obtained with a schedule of ten mg/kg every two weeks bevacizumab was approved by the FDA for recurrent glioblastomas. Due to the negative results concerning overall survival of patients receiv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4849b13374b791d241cc6d6f2b98235
https://doi.org/10.1016/j.bulcan.2018.07.010
Zobrazit plný text záznamu
2
Akademický článek
Correction: Common Genetic Variants and Modification of Penetrance of -Associated Breast Cancer.
Autor: Mia M. Gaudet, Tomas Kirchhoff, Todd Green, Joseph Vijai, Joshua M. Korn, Candace Guiducci, Ayellet V. Segrè, Kate McGee, Lesley McGuffog, Christiana Kartsonaki, Jonathan Morrison, Sue Healey, Olga M. Sinilnikova, Dominique Stoppa-Lyonnet, Sylvie Mazoyer, Marion Gauthier-Villars, Hagay Sobol, Michel Longy, Marc Frenay, GEMO Study Collaborators, Frans B. L. Hogervorst, Matti A. Rookus, J. Margriet Collée, Nicoline Hoogerbrugge, Kees E. P. van Roozendaal, Marion Piedmonte, Wendy Rubinstein, Stacy Nerenstone, Linda Van Le, Stephanie V. Blank, Trinidad Caldés, Miguel de la Hoya, Heli Nevanlinna, Kristiina Aittomäki, Conxi Lazaro, Ignacio Blanco, Adalgeir Arason, Oskar T. Johannsson, Rosa B. Barkardottir, Peter Devilee, Olofunmilayo I. Olopade, Susan L. Neuhausen, Xianshu Wang, Zachary S. Fredericksen, Paolo Peterlongo, Siranoush Manoukian, Monica Barile, Alessandra Viel, Paolo Radice, Catherine M. Phelan, Steven Narod, Gad Rennert, Flavio Lejbkowicz, Anath Flugelman, Irene L. Andrulis, Gord Glendon, Hilmi Ozcelik, Amanda E. Toland, Marco Montagna, Emma D'Andrea, Eitan Friedman, Yael Laitman, Ake Borg, Mary Beattie, Susan J. Ramus, Susan M. Domchek, Katherine L. Nathanson, Tim Rebbeck, Amanda B. Spurdle, Xiaoqing Chen, Helene Holland, Esther M. John, John L. Hopper, Saundra S. Buys, Mary B. Daly, Melissa C. Southey, Mary Beth Terry, Nadine Tung, Thomas V. Overeem Hansen, Finn C. Nielsen, Mark H. Greene, Phuong L. Mai, Ana Osorio, Mercedes Durán, Raquel Andres, Javier Benítez, Jeffrey N. Weitzel, Judy Garber, Ute Hamann, Susan Peock, Margaret Cook, Clare Oliver, Debra Frost, Radka Platte, D. Gareth Evans, Fiona Lalloo, Ros Eeles, Louise Izatt, Lisa Walker, Jacqueline Eason, Julian Barwell, Andrew K. Godwin, Rita K. Schmutzler, Barbara Wappenschmidt, Stefanie Engert, Norbert Arnold, Dorothea Gadzicki, Michael Dean, Bert Gold, Robert J. Klein, Fergus J. Couch, Georgia Chenevix-Trench, Douglas F. Easton, Mark J. Daly, Antonis C. Antoniou, David M. Altshuler, Kenneth Offit
Publikováno v: PLoS Genetics, Vol 6, Iss 11 (2010)
Externí odkaz: https://doaj.org/article/56c8ac479f4f455e97582f1c930791e8
Zobrazit plný text záznamu
3
Akademický článek
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
Autor: Mia M Gaudet, Tomas Kirchhoff, Todd Green, Joseph Vijai, Joshua M Korn, Candace Guiducci, Ayellet V Segrè, Kate McGee, Lesley McGuffog, Christiana Kartsonaki, Jonathan Morrison, Sue Healey, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, Sylvie Mazoyer, Marion Gauthier-Villars, Hagay Sobol, Michel Longy, Marc Frenay, GEMO Study Collaborators, Frans B L Hogervorst, Matti A Rookus, J Margriet Collée, Nicoline Hoogerbrugge, Kees E P van Roozendaal, HEBON Study Collaborators, Marion Piedmonte, Wendy Rubinstein, Stacy Nerenstone, Linda Van Le, Stephanie V Blank, Trinidad Caldés, Miguel de la Hoya, Heli Nevanlinna, Kristiina Aittomäki, Conxi Lazaro, Ignacio Blanco, Adalgeir Arason, Oskar T Johannsson, Rosa B Barkardottir, Peter Devilee, Olofunmilayo I Olopade, Susan L Neuhausen, Xianshu Wang, Zachary S Fredericksen, Paolo Peterlongo, Siranoush Manoukian, Monica Barile, Alessandra Viel, Paolo Radice, Catherine M Phelan, Steven Narod, Gad Rennert, Flavio Lejbkowicz, Anath Flugelman, Irene L Andrulis, Gord Glendon, Hilmi Ozcelik, OCGN, Amanda E Toland, Marco Montagna, Emma D'Andrea, Eitan Friedman, Yael Laitman, Ake Borg, Mary Beattie, Susan J Ramus, Susan M Domchek, Katherine L Nathanson, Tim Rebbeck, Amanda B Spurdle, Xiaoqing Chen, Helene Holland, kConFab, Esther M John, John L Hopper, Saundra S Buys, Mary B Daly, Melissa C Southey, Mary Beth Terry, Nadine Tung, Thomas V Overeem Hansen, Finn C Nielsen, Mark H Greene, Phuong L Mai, Ana Osorio, Mercedes Durán, Raquel Andres, Javier Benítez, Jeffrey N Weitzel, Judy Garber, Ute Hamann, EMBRACE, Susan Peock, Margaret Cook, Clare Oliver, Debra Frost, Radka Platte, D Gareth Evans, Fiona Lalloo, Ros Eeles, Louise Izatt, Lisa Walker, Jacqueline Eason, Julian Barwell, Andrew K Godwin, Rita K Schmutzler, Barbara Wappenschmidt, Stefanie Engert, Norbert Arnold, Dorothea Gadzicki, Michael Dean, Bert Gold, Robert J Klein, Fergus J Couch, Georgia Chenevix-Trench, Douglas F Easton, Mark J Daly, Antonis C Antoniou, David M Altshuler, Kenneth Offit
Publikováno v: PLoS Genetics, Vol 6, Iss 10, p e1001183 (2010)
The considerable uncertainty regarding cancer risks associated with inherited mutations of BRCA2 is due to unknown factors. To investigate whether common genetic variants modify penetrance for BRCA2 mutation carriers, we undertook a two-staged genome
Externí odkaz: https://doaj.org/article/c7a705a431ab474c952a747fa473b1e8
Zobrazit plný text záznamu
4
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
Autor: H. Wiesinger, Ulrich Bogdahn, Jacoline E C Bromberg, Alicia Tosoni, J.M.M. Gijtenbeek, Peter Hau, W.T.A. van der Graaf, Anouk Allgeier, Denis Lacombe, Marc Frenay, Mario Campone, Alba A. Brandes, Roger Stupp, Hwan Jung Yun, M. J. van den Bent, L. Breimer, Thierry Gorlia
Publikováno v: Annals of Oncology, 22, 2144-9
Annals of Oncology, 22, 9, pp. 2144-9
Annals of Oncology, vol. 22, no. 9, pp. 2144-2149
Annals of Oncology
Annals of Oncology, 22(9), 2144-2149. Elsevier Ltd.
Item does not contain fulltext BACKGROUND: Sagopilone (ZK 219477), a lipophylic and synthetic analog of epothilone B, that crosses the blood-brain barrier has demonstrated preclinical activity in glioma models. PATIENTS AND METHODS: Patients with fir
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff761ff942a5427a762451d3bee2780
http://doc.rero.ch/record/291521/files/mdq729.pdf
Zobrazit plný text záznamu
5
Gliomes et mutations des gènes BRCA: association fortuite ou imputabilité?
Autor: Véronique Mari, Laura Girardstein-Boccara, Fanny Burel-Vandenbos, Philippe Paquis, Pascaline Berthet, Christine Lebrun-Frenay, Marie Met-Domestici, Marc Frenay
Publikováno v: Bulletin du Cancer. 101:795-802
BRCA is a tumor suppressor gene implicated in the major mechanisms of cellular stability in every type of cell. Its mutations are described in numerous cancers, mainly breast and ovarian in women. It was also found an increase of lifetime risk of pan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7f89620b99452ac85b186aabe9229b0
https://doi.org/10.1684/bdc.2014.1952
Zobrazit plný text záznamu
6
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF
Autor: C. Dalban, F. Bonnetain, Jeremy Skrzypski, H. Taillia, Bruno Chauffert, Jean-Sébastien Guillamo, Daniel Castera, Didier Frappaz, Marc Frenay, L. Feuvret, Isabelle Tennevet, Jérôme Honnorat, Roland Schott, Luc Taillandier, Chantal Campello, Olivier Chinot, François Ghiringhelli, Michel Fabbro, Xavier Durando
Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2014, 25 (7), pp.1442-1447. ⟨10.1093/annonc/mdu148⟩
Background Prognosis of unresectable glioblastoma (GB) remains poor, despite temozolomide (TMZ)-based chemoradiation. Activity of bevacizumab (BEV) and irinotecan (IRI) has been reported in recurrent disease. We evaluated BEV and IRI as neo-adjuvant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a206973777a5dffc6b1bf2f39f8c25
https://doi.org/10.1093/annonc/mdu148
Zobrazit plný text záznamu
7
GENESIS: a French national resource to study the missing heritability of breast cancer
Autor: Sylvie Mazoyer, Valérie Layet, Carole Verny-Pierre, Claude Adenis, Marie-Gabrielle Dondon, Isabelle Mortemousque, Morgane Marcou, Olga M. Sinilnikova, Philippe Jonveaux, Anne Floquet, François Eisinger, Yves-Jean Bignon, Catherine Noguès, Laurence Gladieff, Capucine Delnatte, Olivier Caron, Bruno Buecher, Pascaline Berthet, Anne Fajac, Clotilde Penet, Séverine Eon-Marchais, Sandra Fert-Ferrer, Florent Soubrier, Dominique Stoppa-Lyonnet, Chrystelle Colas, Isabelle Coupier, Christine Lasset, Emmanuelle Barouk-Simonet, Michel Longy, Jean-Pierre Fricker, Jean Chiesa, Sophie Giraud, Dominique Leroux, Catherine Dugast, Sophie Lejeune-Dumoulin, Hélène Dreyfus, Annie Chevrier, Odile Cohen-Haguenauer, Thierry Frebourg, Liliane Demange, Julie Tinat, Fabienne Lesueur, Pascal Pujol, Emmanuelle Mouret-Fourme, Elisabeth Luporsi, Christine Maugard, Dorothée Le Gal, Noura Mebirouk, Séverine Audebert-Bellanger, Laure Barjhoux, Muriel Belotti, Eve Cavaciuti, Marion Gauthier-Villars, Marie-Agnès Collonge-Rame, Paul Gesta, Jean-Marc Limacher, Odile Bera, Lucie Toulemonde, Anne Tardivon, Fabienne Prieur, Laurence Faivre, Juana Beauvallet, Alain Lortholary, Nadine Andrieu, François Cornelis, Marc Frenay, Valérie Sornin, Laurence Venat-Bouvet, Francesca Damiola, Valérie Bonadona
Publikováno v: BMC Cancer
BMC Cancer, 2016, 16 (1), pp.606-606. ⟨10.1186/s12885-015-2028-9⟩
BMC Cancer, BioMed Central, 2016, 16 (1), pp.606-606. ⟨10.1186/s12885-015-2028-9⟩
Background Less than 20 % of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e441c687b1238500e6c41a65dcf7ba
https://hal.univ-lorraine.fr/hal-01662200/document
Zobrazit plný text záznamu
10
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma
Autor: Khê Hoang-Xuan, Jean-Yves Delattre, László Sipos, Martin J.B. Taphoorn, Hans J.J.A. Bernsen, Denis Lacombe, Marc Frenay, Alba A. Brandes, Thierry Gorlia, Martin J. van den Bent, Charles J. Vecht, Roelien H. Enting, Johan M. Kros, Cees C. Tijssen, Pim J. French, Mathilde C.M. Kouwenhoven, Winand N.M. Dinjens, Anouk Allgeier, Wolfgang Grisold
Publikováno v: Journal of Clinical Oncology, 31(3), 344-350. American Society of Clinical Oncology
van den Bent, M J, Brandes, A A, Taphoorn, M J B, Kros, J M, Kouwenhoven, M C M, Delattre, J Y, Bernsen, H J J A, Frenay, M, Tijssen, C C, Grisold, W, Sipos, L, Enting, R H, French, P J, Dinjens, W N M, Vecht, C J, Allgeier, A, Lacombe, D, Gorlia, T & Hoang-Xuan, K 2013, ' Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 ', Journal of Clinical Oncology, vol. 31, no. 3, pp. 344-350 . https://doi.org/10.1200/JCO.2012.43.2229
Journal of Clinical Oncology, 31(3), 344-350. AMER SOC CLINICAL ONCOLOGY
Purpose Anaplastic oligodendroglioma are chemotherapy-sensitive tumors. We now present the long-term follow-up findings of a randomized phase III study on the addition of six cycles of procarbazine, lomustine, and vincristine (PCV) chemotherapy to ra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6347dec5dc9d93f4efcc0269e67e01
https://doi.org/10.1200/JCO.2012.43.2229
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje